# Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain

> **NCT00384579** · PHASE4 · TERMINATED · sponsor: **United States Department of Defense**

## Conditions studied

- Low Back Pain

## Interventions

- **DRUG:** Botulinum toxin B
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00384579
- **Lead sponsor:** United States Department of Defense
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No eligible candidates in 2 years of recruiting
- **Last updated:** 2010-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00384579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00384579, "Pilot Study to Assess the Efficacy of Botulinum Toxin B on Pain and Disability in Subjects With Acute Low Back Pain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00384579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*